uring virus infection, NK cells are needed in the body to provide early immune defense. Their activity is regulated by MHC class I-binding cell surface inhibitory and stimulatory receptors that include mouse Ly49, human killer Igrelated receptor (KIR), 3 and NKG2/CD94 receptors (1-3). NK cell-mediated virus control is subject to genetic factors that can influence viral replication and host mortality (4). For instance, the Ly49H activation receptor displayed on the surface of NK cells in C57BL/6 mice binds murine CMV (MCMV) m157 ligands at the surface of infected cells to impart MCMV resistance (5, 6). In New Zealand White, MA/My, and PWK strains, MCMV resistance also requires NK-mediated virus control, but Ly49H-independent defense mechanisms are key (7-11). It remains unclear which genetic factors are at work and how such factors mediate virus resistance through NK cells.
D
uring virus infection, NK cells are needed in the body to provide early immune defense. Their activity is regulated by MHC class I-binding cell surface inhibitory and stimulatory receptors that include mouse Ly49, human killer Igrelated receptor (KIR), 3 and NKG2/CD94 receptors (1-3). NK cell-mediated virus control is subject to genetic factors that can influence viral replication and host mortality (4) . For instance, the Ly49H activation receptor displayed on the surface of NK cells in C57BL/6 mice binds murine CMV (MCMV) m157 ligands at the surface of infected cells to impart MCMV resistance (5, 6) . In New Zealand White, MA/My, and PWK strains, MCMV resistance also requires NK-mediated virus control, but Ly49H-independent defense mechanisms are key (7) (8) (9) (10) (11) . It remains unclear which genetic factors are at work and how such factors mediate virus resistance through NK cells.
Attempts have been made to identify genetic factors that underlie MCMV resistance/susceptibility traits in the offspring of genetic crosses between MCMV-resistant (Cmv r ) MA/My mice and strains that appear to be more MCMV susceptible (Cmv s ). To date, major MCMV control loci have been mapped to the MHC and NK gene complex (NKC) on chromosomes 17 and 6, respectively (9, 10) . We have further shown that MHC polymorphism is responsible for genetic variations in NK-mediated virus resistance in C57L.M-H2 k and MA/My.L-H2 b congenic mice (10, 12) . To pin down an MCMV control (Cmv r ) locus within the MHC, we generated a genetic mapping panel of 13 H-2 k recombinant congenic lines on the C57L (Cmv s ) genetic background. Recombination breakpoints were definitively mapped and MCMV resistance/susceptibility traits determined for each of the new lines so that the MHC Cmv r locus could be identified. Interestingly, virus infection clearly distinguished MCMV control in two of the novel lines, C57L.M-H2 k (R2) (Cmv s ; referred to hereafter as R2) and C57L.M-H2 k (R7) (Cmv r ; referred to hereafter as R7), which only differ by ϳ0.3 megabases (Mb) of DNA within the MHC. We further examined the role of NK subsets in MHC H-2 k resistance to MCMV infection. We propose that the novel recombinant strains represent a powerful new model for investigating MHC regulation of NK-mediated virus immunity. k (L.M-H2 k ) mice were bred and maintained in a specificpathogen-free vivarium at the University of Virginia (Charlottesville, VA), which is fully certified by the American Association for Accreditation of Laboratory Animal Care. All recombinant congenic strains generated and used in this study were backcrossed to the progenitor strain C57L for at least 10 generations. All animal studies were approved by and conducted in accordance with the Institutional Animal Care and Use Committee (IACUC) of the University of Virginia.
Materials and Methods

Animals
Recombinant congenic strain generation, genetic markers, and genotyping (C57L.M-H2
k ϫ C57L)F 1 or (MA/My.L-H2 b ϫ MA/My)F 1 were brother ϫ sister mated and screened for recombination crossovers within the D17Mit16-D17Uva09 interval using several simple sequence-length polymorphism (SSLP) markers to distinguish MA/My and C57L alleles (Table I) . SSLP-amplified PCR products were resolved in POP7-filled capillaries and analyzed on a Genetic Analyzer 3130xl using Data Collection (version 3.0) and GeneMapper software (version 4.0; Applied Biosystems) as described previously (10) . Some unlabeled SSLP amplicons were fractionated in 4% agarose gel electrophoresis and visualized on an UV transilluminator after ethidium bromide staining.
For generation of novel SSLP markers, chromosome 17 sequence data available from the National Center for Biotechnology Information were manually inspected for microsatellite repeat sequences. Sequence-specific primers were designed and tested for specific amplification of microsatellites and capacity for distinguishing SSLPs (Table I) . Single nucleotide polymorphism (SNP) markers rs13482961 and rs13482963 were amplified on the iCycler iQ real-time PCR detection system (Bio-Rad) according to the manufacturer's protocol (TaqMan SNP Genotyping Assays; Applied Biosystems).
Mice with intra-region recombinations were confirmed and further backcrossed to the C57L or MA/My genetic background, followed by more (Table II) was generated and genotyped with genetic markers (Table I) extensive genetic analysis to pinpoint chromosome crossovers as we have described previously (13) . The novel recombinant lines have been maintained at the University of Virginia in accordance with IACUC guidelines.
Abs and flow cytometry
Anti-mouse CD3 (145-2C11) PerCP and allophycocyanin, NK1.1 (PK136) PE, CD49b (DX5) PE, Ly49G2 (4D11) FITC, and CD8␣ (53-6.7) PE and streptavidin-PerCP were purchased from BD Pharmingen. Anti-mouse CD4 (RM4-4) FITC, NK1.1 (PK136) PE-Cy7, Ly49C/I/F/H (14B11) biotin, NKG2D (CX5) PE, Ly49G2 (AT8) biotin, streptavidin-allophycocyanin-Cy7, and perforin (Prf1; eBioOMAK-D) allophycocyanin were purchased from eBioscience. Anti-mouse CD69 (H1.2F3) allophycocyanin was purchased from BioLegend. Anti-mouse NKp46 (goat IgG) PE was purchased from R&D Systems. Dr. W. Yokoyama (Washington University School of Medicine, St. Louis, MO) provided the PK136 hybridoma. Dr. T. Bullock (University of Virginia Health System, Charlottesville, VA) provided rat IgG. The rat LGL-1 hybridoma 4D11 was purchased from American Type Culture Collection (ATCC). Purified PK136 and 4D11 mAbs were obtained from hybridoma supernatants at the University of Virginia Lymphocyte Culture Center (Charlottesville, VA).
Staining of spleen leukocyte surface Ags was performed as described previously (10) . For intracellular perforin staining, cells were first stained for cell surface markers and then fixed and permeabilized using the Cytofix/Cytoperm kit (BD Pharmingen). All Ab stains were performed on ice. Ab-labeled cells were analyzed by flow cytometry on a FACScan device (BD Biosciences) and data were analyzed using FlowJo (version 8.0, Tree Star).
Virus assays
Stock salivary gland virus (SGV; Smith Strain, ATCC no.VR194) was prepared after serial passage in BALB/c mice and titered on NIH 3T3 or NIH 3T12 monolayers as described (10, 12) . SGV stocks 3.1.05 and 8.3.07 (LD 50 ϭ 1 ϫ 10 5 PFU) stocks were used in this study. Experimental mice (8 -12 wk) were i.p. infected with SGV (10 5 PFU or as indicated). To study the role of NK cells during MCMV infection, mice were i.p. injected with 200 g of anti-NK1.1 mAb PK136 48 h before and, where noted, immediately before MCMV infection. Ly49G2 ϩ NK cells were similarly depleted using 200 g of anti-Ly49G2 mAb 4D11 given 48 h before MCMV infection. NK cell depletions from spleen were confirmed by flow cytometry using anti-NKp46, anti-CD49b, and anti-Ly49G2 AT8. For T cell depletions, mice were i.p. injected daily with 200 g each of GK1.5 (anti-CD4) and 2.43 (anti-CD8) mAbs for three consecutive days (days Ϫ5, Ϫ4, and Ϫ3) and one more dose three days later immediately before MCMV infection (day 0). T cell depletions were confirmed by flow cytometry using anti-CD4 and anti-CD8 mAb clones other than those used as depleting Abs (data not shown). Spleens and livers were collected from euthanized mice 3.5 days postinfection for virus quantitation using quantitative real-time PCR as described previously (12) . MCMV genome levels (average for triplicate measurements) were reported as the log 10 (number of MCMV genomic copies/number of ␤-actin genomic copies).
Results
H-2 k MCMV resistance mapped to the class I D subregion
To identify a critical MCMV resistance interval between SSLP markers D17Mit16 and D17Mit10 (12), we generated a mapping ) backgrounds. We screened for recombinant animals using a panel of SSLP genetic markers that distinguish MA/My and C57L alleles (Table I and Fig. 1A ). In total, 17 recombinant lines were isolated (Table II) ; seven lines have been depicted in Fig. 1 with recombinant chromosome crossover intervals in each of the lines mapped. For example, R2 mice retained MA/My-derived alleles in the D17Mit16-17Uva12 interval and only C57L-derived alleles for 17Uva01 and markers distal to it (Table II and Fig. 1A) . Thus, the R2 crossover was bounded by 17Uva12 and 17Uva01. Likewise, R7 mice retained MA/My-derived alleles in the D17Mit16-H-2 D interval and C57L-derived alleles for 17Uva03 and markers distal to it. Thus, the R7 crossover occurred between H-2 D and 17Uva03. A similar strategy was used to locate crossovers for each of the recombinant lines; together, the lines established a valuable genetic mapping resource.
We next separately backcrossed each new mouse line with C57L to generate heterozygous offspring. About half of the offspring received a recombinant chromosome haplotype, and the other half received a nonrecombinant C57L.M-H2 k -derived haplotype. We compared the recombinant offspring and their nonrecombinant littermates for MCMV control traits by assessing spleen and liver (data not shown) virus genome levels 3.5 days after infection. As shown in Fig. 2 , only low MCMV titers were observed in R6, R7, R8, and R12 spleens, similar to R6-LM littermate control spleen. Thus, a MCMV resistance (Cmv r ) locus should reside in the region of overlap. In contrast, MCMV was substantially higher in R2, R3, and R4 spleens than in R3-LM and R4-LM littermates, indicating that MA/My-derived haplotypes retained in these recombinant lines are insufficient in MCMV resistance. Altogether, the data in Fig. 2 pointed toward a critical interval bounded by R2 and R7 crossovers. An H-2 k Cmv r locus was first placed in the H-2 S-D region flanked by the markers 17Uva12 and 17Uva03.
To refine the locus, R2, R7, and R12 were genotyped with additional allele-specific markers located near the H-2 class I D gene (Table III and Fig. 1 ). By this strategy, R2 and R7 crossovers were mapped between 17Uva20 and SNP rs13482961 and 17Uva17 and 17Uva03, respectively. Thus, an H-2 k Cmv r locus must be flanked by markers 17Uva20 and 17Uva03, an ϳ0.3-Mb interval that spans 30 genes including the class I D gene (supplemental Fig.  S1 ). 4 In accordance with this, R12, which arose spontaneously from the R7 line, also displays the resistance phenotype (Fig. 2) . 4 The online version of this article contains supplemental material. 
a Chromosome 17 locus markers (see Table I ) used to determine MA/My (M) or C57L (L) alleles for the recombinant chromosome in each line are shown. Some alleles are not determined (ND).
b Recombinant lines were generated on C57L (denoted as R) or MA/My (denoted as MR) backgrounds.
NK cells are required in H-2 k MCMV resistance
To assess their role in resistance, we depleted NK cells from R7 (Cmv r ) mice before MCMV infection. Our previous work had shown that the anti-NK1.1 mAb PK136 does not efficiently deplete NK cells from mice on the C57L (NK1.1 c57l ) background (10). Consequently, when C57L.M-H2 k/b -NKC mamy/c57l mice with an NK1.1 c57l allele were given PK136 treatment before MCMV infection, only a partial loss of splenic MCMV resistance was observed (10) . Residual MCMV control was likely due to ineffective depletion of NK cells from NK1.1 c57l mice (data not shown). To achieve efficient NK depletion, the NKC mamy haplotype was crossed onto the R7 genetic background and homozygous R7-NKC mamy animals were generated. As shown in Fig. 3A , PK136 treatment efficiently depleted ϳ78 and Ͼ93% of splenic NKp46 ϩ NK cells from R7-NKC het (where het stands for heterozygous) and R7-NKC mamy mice, respectively. Similar results were obtained by 
a H-2 locus markers (see Table I (10), MCMV control in R7-NKC het mice was consistently more dramatically altered in the liver than in the spleen (Fig. 3B) . Nonetheless, PK136 depletion of R7-NKC mamy NK cells fully abrogated spleen and liver MCMV control (Fig. 3B) . We conclude that NK cells are essential for MHC H-2 k MCMV resistance. Strains R2 and R7 establish an excellent model system to investigate NK-mediated virus immunity under MHC genetic control.
To address a potential role for other lymphocyte subsets, we also assessed resistance in mice after depletion of CD4 and CD8 T 
, CD3, and Ly49G2 (4D11). Numbers indicate the mean percentage of NK cells expressing Ly49G2
ϩ at the cell surface at the indicated times after MCMV infection. C, As in B, but the values represent total numbers of Ly49G2 ϩ and Ly49G2 Ϫ NK cells in R2 and R7 spleens after infection. R2 NK cells in spleen, regardless of Ly49G2 expression, decreased at 90 h after infection (p Ͻ 0.005). In R7 spleen, Ly49G2 Ϫ NK cells decreased by 39 h after infection and were still significantly lower than in control spleen at 90 h after infection (p Ͻ 0.005). In contrast, only R7 Ly49G2 ϩ NK cells increased significantly between 39 and 90 h after infection until they were also higher than those in uninfected R7 spleen (p Ͻ 0.05). D, Groups of R7 mice were infected with the indicated dose of MCMV. Shown are average MCMV genome levels for spleen (E) and liver (F) at 90 h after infection. The limit of MCMV detection (dashed line) is indicated. E and F, Splenocytes from R7 mice in D were stained for NK1.1, Ly49G2 (4D11), and cell surface CD69 (E) or intracellular perforin (F). Plots show MCMV genome levels and mean fluorescence intensity (MFI) values for Ly49G2
Ϫ (E) and Ly49G2 ϩ (F) NK cell subsets for individual animals. The correlation exponential trend lines with R 2 values are shown. Data are representative of at least two independent experiments. Error bars indicate SD. Statistical analysis was performed using a Student's t test. cells, because the importance of both subsets has been established (14, 15) . Furthermore, recent work has shown that in BALB.Klra8 congenic mice with Ly49H resistance, MCMV-specific activated CD8 T cells in the spleen can be detected by day 4 postinfection (16). As shown in Fig. 3C , T cell depletions failed to alter MCMV replication in the spleens or livers of infected mice, and thus these cells have no measurable impact on early MHC H-2 k MCMV resistance.
Selective activation and expansion of Ly49G2 ϩ NK cells confers H-2 k MCMV resistance
The activating Ly49H receptor mediates NK-dependent MCMV control in B6 mice (17) (18) (19) . In accordance with this, Ly49H ϩ NK cells specifically expand and proliferate to counter MCMV (20) . We therefore hypothesized that some NK cells might undergo selective expansion and/or activation in R7 (Cmv r ) mice during infection. Ly49G2 is an especially interesting inhibitory NK cell receptor because Ly49G2 129 can bind MHC class I D k as a ligand (21, 22) . In addition, we found that only one amino acid difference distinguishes Ly49G2 mamy from Ly49G2 c57l and Ly49G2 129 alleles (our unpublished data). Thus, NK cell subset responses were examined in R2 and R7 mice at discrete times after MCMV infection.
To examine Ly49
ϩ NK subsets responding to MCMV, we stained splenic NK cells using the anti-Ly49 mAbs 14B11 (panspecific for Ly49C/I/F/H) and 4D11 (Ly49G2-specific) before and after infection in R2 (Cmv s ) and R7 (Cmv r ) congenic strains. As expected, splenic MCMV was substantially higher in R2 than R7 after 90 h (Fig. 4A) . We found that 45-50% of NK cells in C57L and MA/My spleens can be stained with mAb 14B11 (data not shown). In contrast, different subsets of NK cells in C57L (ϳ50%) or MA/My (ϳ30%) express Ly49G2 on the cell surface (data not shown). In R2 and R7 (both on the C57L genetic background) mice, 50 -60% of NK cells display Ly49G2 on the cell surface before infection (Fig. 4B) .
Comparison of 14B11 ϩ and 14B11 Ϫ NK cells in R2 and R7 mice revealed little if any change in either percentage or cell numbers after infection (data not shown). In contrast, a slight increase in the percentage of Ly49G2 ϩ NK1.1 ϩ CD3 Ϫ NK cells was observed in R2 spleen by 39 h after infection, and the percentage of Ly49G2 ϩ NK1.1 ϩ CD3 Ϫ NK cells rose steadily through 90 h after infection in R7 spleen (Fig. 4B) . Even so, splenic NK cells showed an overall decline in number in both strains by 39 h after infection (Fig. 4C) , which is consistent with splenic NK cells responding to MCMV in B6 mice (19, 20, 23) . After 39 h, however, Ly49G2 ϩ NK cells increased significantly in R7 mice to a level that For both virus doses, 4D11-treated spleen virus levels were significantly higher than those of rat IgG-treated animals (p Ͻ 0.005), although not significantly different than those of PK136-treated animals. At the lower dose, 4D11-treated liver virus levels were significantly higher than those in IgG-treated animals (p Ͻ 0.05) but significantly lower than those in PK136-treated animals (p Ͻ 0.05). Statistical analysis was performed using a Mann-Whitney/Wilcoxon test. Data included three to nine mice per group. H-2 D k LOCUS AND Ly49G2 ϩ NK CELLS CONFER MCMV RESISTANCE exceeded steady-state levels in uninfected controls (Fig. 4C) . This was not the case for Ly49G2 Ϫ NK cells in R7 mice or either subset in R2 mice (Fig. 4C) . We have observed a similar expansion of Ly49G2 ϩ NK cells in infected MA/My mice (data not shown). These data are congruent with the finding of Welsh and colleagues showing a proportional increase in Ly49G2 ϩ NK cells after MCMV infection in B6 mice (19, 23) . More remarkable, however, the absolute number of Ly49G2 ϩ NK cells and the proportion of NK cells are significantly augmented under H-2 k control. These data therefore indicate that splenic Ly49G2 ϩ NK cells are selectively expanded in response to MCMV infection in R7 mice with highly efficient H-2 k NK-mediated virus control. We have previously shown that the peak and extent of NK intracellular IFN-␥ in response to MCMV is similar in MA/My and C57L mice (12) . Thus, we examined R2 and R7 NK cells for cell surface CD69 and intracellular perforin (Prf1) expression in response to MCMV. We delivered MCMV to mice in a dose range that yielded different spleen (ϳ1,000-fold variation) and liver (ϳ100-fold variation) MCMV levels by 90 h after infection. In accordance with previous NK IFN-␥ data (12), CD69 activation in R2 and R7 NK cells correlated well with splenic MCMV (data not shown). In addition, Ly49G2 ϩ and Ly49G2 Ϫ NK cells in R7 had enhanced CD69 expression that corresponded with spleen MCMV (Fig. 4E) .
We next examined perforin in NK cells responding to MCMV. Similar to CD69 expression, R7 Ly49G2 ϩ NK cells expressed perforin levels that corresponded directly to splenic MCMV over a wide range (Fig. 4F) . In contrast, perforin levels in R7 Ly49G2 Ϫ NK cells did not correlate with spleen MCMV loads in the inoculation range of 10 4 to 5 ϫ 10 5 PFU (Fig. 4F) . We further observed peak expansion of total NK cells and a maximal Ly49G2 ϩ / Ly49G2 Ϫ NK cell ratio in R7 mice given 10 5 PFU of MCMV at 90 h after infection (supplemental Fig. S2B ). In contrast, Ly49G2 ϩ NK cells in R2 mice declined by 3-fold even at the lowest MCMV dose tested (supplemental Fig. S2A ). Hence, MCMV provoked potent induction of perforin and acquisition of cytolytic effector status by Ly49G2 ϩ NK cells in R7 mice. We conclude that R7 Ly49G2 ϩ NK cells preferentially expand and become activated during MCMV infection due to the MHC class I D k subregion. To discern their involvement in virus resistance, Ly49G2 ϩ NK cells were depleted from R7 (Cmv r ) mice using mAb 4D11 given before infection. In spleens of 4D11-treated R7 mice we found a selective loss of ϳ35% of NKp46 ϩ CD3 Ϫ CD19 Ϫ splenocytes, and the residual NK cells (includes 14B11 ϩ and 14B11 Ϫ ) in these animals were refractory to staining with 4D11 or AT8 (also Ly49G2-specific) (Fig. 5A) . Intriguingly, 4D11 treatment also significantly diminished resistance such that virus replication was enhanced in spleen and liver in animals after MCMV infection (Fig.  5, B and C) . In comparison, PK136 depletion of most NK1.1 ϩ cells gave an effect comparable in magnitude. Inasmuch as Ly49G2 NK subset depletion from C57BL/6 mice using 4D11 or 4LO439 mAbs given before infection has no effect on resistance in the spleen or liver (23, 24) , our data indicate that Ly49G2 ϩ NK-mediated resistance is selective and that residual NK subsets are ineffective in this genetic setting. We conclude that the H-2 k class I D locus confers MCMV resistance through Ly49G2 ϩ NK cells in R7 mice.
Discussion
H-2 k genetic resistance to lethal MCMV infection was previously mapped to MHC K/I-A and -D intervals using MHC recombinant congenic mice (25) . Later, a key role for NK-mediated MCMV resistance in MA/My mice was shown (7). Only recently however, has it come to light that MA/My resistance is largely affected by a dominant H-2 k locus that can contribute MCMV control through epistatic (9) or additive (Ref. 10 and M. D. Stadnisky and M. G. Brown, unpublished data) interaction with an NKC locus on chromosome 6. Although we did not observe a K/I-A-associated resistance effect in this study, distinct background gene or allele effects in C3H, B10, and BALB.K strains could have influenced H-2 k resistance to MCMV mortality in the former study (25) . Nevertheless, in the current study we extended precise genetic mapping for an H-2 k Cmv r locus to a narrow class I D interval spanning 0.3 Mb of DNA with roughly 30 genes.
Although multiple genes at this locus encode proteins with at least some immune function, EG667612, lymphotoxin, TNF, and class I D genes are especially interesting in consideration of a possible role in virus resistance. The EG667612 sequence includes an Ncr3 pseudogene for mouse NKp30, and it is not expressed in a variety of different mouse strains (26) Only Ly49H has to date been coupled with virus recognition and resistance due to specific binding to its m157 ligand displayed by MCMV-infected cells (5, 6) . Also implicated in MCMV recognition and resistance, Ly49P ϩ reporter cells can respond specifically to D k -expressing, MCMV-infected cells (9) . In support of a potential in vivo role, a pan-specific anti-Ly49 mAb, YE1/48, with reactivity for Ly49A/P/V/T given before infection, can interfere with MCMV resistance in MA/My mice (9) . Genetic map analysis in the current work establishes a critical involvement for the MHC-I D k locus in vivo. We found unexpectedly that Ly49G2 (19, 23) . Ly49G2 is therefore not a bona fide marker for NK cells providing protection from MCMV infection in C57BL/6 animals. In stark contrast with MCMV resistance manifest in the C57BL/6 strain, we found in this study that Ly49G2-depleted R7 animals with ϳ65% of NKp46 ϩ NK cells intact were severely deficient for MCMV resistance. Other NK cell subsets were therefore unable to effectively deliver MCMV resistance in this system. Altogether, these data substantiate a likely critical role, one influenced by MHC genetic variation, for Ly49G2 ϩ NK cells in MCMV resistance in the R7 strain.
The mAb 4D11 likely binds specifically the inhibitory Ly49G2 c57l receptors expressed by R7 NK cells for several reasons: 1) we found that the C57L and 129 NKC-Ly49 haplotypes are highly related, if not identical (31); 2) sequence analysis of Ly49G2 c57l revealed that it is identical to Ly49G2 129 and Ly49G2 mamy differs by one amino acid (our unpublished data); 3) 4D11 was shown to be specific for Ly49G2 receptors on C57BL/6, BALB/c, C3H, and 129 NK cells (32, 33) ; and 4) another Ly49G2 allele-specific mAb, AT8 (33) , similarly costained IL-2-activated 4D11 ϩ NK cells from 129, R2-NKC mamy , and R7-NKC mamy mice (supplemental Fig. S3 ). Primary 4D11 ϩ NK cells from uninfected and MCMV-infected R7-NKC mamy mice were also costained with the mAb AT8 (data not shown). Collectively, these data substantiate the specific recognition by the mAb 4D11 of Ly49G2 c57l and Ly49G2 mamy NK receptors. It has been shown that Ly49H ϩ splenic NK cells, which are needed for MCMV control in C57BL/6 mice, preferentially expand by day 6 after infection (20) ϩ NK cells selectively expanded and became activated for cytolytic function in R7 spleen. Thus, although the actual role of Ly49G2 in NK activation must still be determined, the Ly49G2 ϩ NK subset may have been more effectively licensed (35) or armed (36) for effector function and/or responsive to cellular alterations in self-MHC class I expression, perhaps due to viral down-regulation of H-2 D k cell surface expression (12) . Consistent with this possibility, inhibitory Ly49G2 balb (where balb is BALB/c) and Ly49G2 129 receptors can specifically bind MHC-I D k (21, 22) and Ly49G2 c57l is identical to Ly49G2 129 (our unpublished data).
Although mouse Ly49 and human KIR receptors are structurally unrelated, they have several features in common including sequence polymorphism, MHC-I recognition, and signaling through ITAM (on coreceptors) or ITIM domains for stimulating or inhibiting NK effector functions, respectively. Recent genetic studies have revealed that certain KIR/HLA combined genotypes associate with resistance or susceptibility to some human diseases (37) , but the mechanistic details have not been elucidated. We propose that further study of NK-mediated virus immunity under MHC genetic control will provide an important model for beginning an examination of a role for NK cell receptors, as they can be influenced by MHC alleles, in virus immunity.
